Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluential
Research works printed but not linked: 3
- D′Incà R., 1993, Can permeability to sugars predict relapses in Crohn′s disease?, Gut, 34, S50
- 10.1016/s0002-9270(03)00703-2 · DOI
- 10.1097/00005176-199210000-00010 · doi:10.1097/00005176-199210000-00010 · Paper page
Cited by
The intestinal barrier: a fundamental role in health and disease
Vancamelbeke, M., & Vermeire, S. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1343143 · Cited by 1,287
“Most in vivo permeability studies report the prevalence of increased gut permeability to be 40–50%, with the highest values for patients with active disease [46].”
BackgroundLeaky gut: mechanisms, measurement and clinical implications in humans
Camilleri, M. (2019) · Gut · doi:10.1136/gutjnl-2019-318427 · Cited by 1,081
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 759
“Local intestinal inflammation underlies the development of a number of gastrointestinal diseases, such as inflammatory bowel disease [43], Crohn’s disease [44], and ulcerative colitis (extensively reviewed recently in [45]).”
BackgroundNegative Effects of a High-Fat Diet on Intestinal Permeability: A Review
Rohr, M. W., Narasimhulu, C. A., Rudeski-Rohr, T. A., & Parthasarathy, S. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz061 · Cited by 751
Intestinal Barrier in Human Health and Disease
Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 533
The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces
Statovci, D., Aguilera, M., MacSharry, J., & Melgar, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00838 · Cited by 482
“Zn given orally to CD patients restored intestinal permeability by modulating TJ proteins in both the small intestine and colon (261).”
IL-1β and the Intestinal Epithelial Tight Junction Barrier
Kaminsky, L. W., Al-Sadi, R., & Ma, T. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767456 · Cited by 432
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health
Vernocchi, P., Del Chierico, F., & Putignani, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01144 · Cited by 426
Hou, Q., Ye, L., Liu, H., Huang, L., Yang, Q., Turner, Jr., & Yu, Q. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0070-2 · Cited by 400
“Although the precise etiology of IBD remains unclear and controversial, the intestinal microbiota and integrity of mucosal epithelial function have been demonstrated to play key roles in its pathogenesis [7– 9].”
Thomas, S., Izard, J., Walsh, E., Batich, K., Chongsathidkiet, P., Clarke, G., Sela, D. A., Muller, A. J., Mullin, J. M., Albert, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2929 · Cited by 367
Wu, J., Wei, Z., Cheng, P., Qian, C., Xu, F., Yang, Y., Wang, A., Chen, W., Sun, Z., & Lu, Y. (2020) · Theranostics · doi:10.7150/thno.43528 · Cited by 393
“depletion of mucus, and exhibited decreased expression of tight junction proteins and microbiota translocation [13].”
BackgroundMitochondria: It is all about energy
Casanova, A., Wevers, A., Navarro-Ledesma, S., & Pruimboom, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1114231 · Cited by 303
“Therefore, improving mitochondrial health is a way to prevent ROS overload and mtDNA deterioration and subsequently improve immune responses (Michielan and D’Incà, 2015; Fasano, 2020; Martel et al., 2022; Akdis, 2021; Rizzetto et al., 2018; Chopyk and Grakoui, 2020; Mou et al., 2022).”
BackgroundImpact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
“Inflammation can decrease the functional surface area of the intestines, but results from various studies indicate that it also can increase intestinal tight junction permeability (Michielan and D'Incà, 2015).”
BackgroundShin, W., & Kim, H. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810819115 · Cited by 309
“Our finding suggests that a person with hyperpermeability of the intestinal epithelium, or so-called leaky gut (9), may be more vulnerable to continuous microbial attacks and aggressive immune infiltration, which can lead to a chronic inflammatory stage because the gut can potentially lose its homeostatic tolerance.”
BackgroundBurrello, C., Garavaglia, F., Cribiù, F. M., Ercoli, G., Lopez, G., Troisi, J., Colucci, A., Guglietta, S., Carloni, S., Guglielmetti, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07359-8 · Cited by 307
Stephens, M., & von der Weid, P.-Y. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1629235 · Cited by 295
“With implications such as fever and sepsis to consider, the so-called “leaky gut” is a method to cause both localized and widespread inflammation.(39) We hypothesized that specific LPS could increase intestinal permeability and therefore allow many different bacteria to spread, not only those who produce the potent im…”
MethodRangan, P., Choi, I., Wei, M., Navarrete, G., Guen, E., Brandhorst, S., Enyati, N., Pasia, G., Maesincee, D., Ocon, V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.019 · Cited by 312
“Based on previously published methods (Yan et al., 2011; Gupta and Nebreda, 2014; Michielan and D’Inca, 2015), mice were fasted for four hours prior to oral gavage with 60mg/100 g of fluorescein isothiocyanate conjugated dextran (FITC-dextran, SigmaAldrich).”
MethodBacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
Anjana, & Tiwari, S. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.851140 · Cited by 264
Koch, F., Thom, U., Albrecht, E., Weikard, R., Nolte, W., Kuhla, B., & Kuehn, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820130116 · Cited by 255
“While dendritic cells recognize pathogen components via their pattern recognition receptors and trigger differentiation of T and natural killer cells, monocytes, Kupffer cells, and macrophages may secrete proinflammatory cytokines (9).”
Araújo, J. R., Tomas, J., Brenner, C., & Sansonetti, P. J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.05.019 · Cited by 261
Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies
Ahluwalia, B., Moraes, L., Magnusson, M. K., & Öhman, L. (2018) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1447597 · Cited by 241
“However, whether barrier impairment is a primary defect or a consequence is still under debate [14].”
BackgroundVindigni, S. M., Zisman, T. L., Suskind, D. L., & Damman, C. J. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16644242 · Cited by 229
Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health
Wan, Z., Zheng, J., Zhu, Z., Sang, L., Zhu, J., Luo, S., Zhao, Y., Wang, R., Zhang, Y., Hao, K., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1031502 · Cited by 194
Revisiting the gut–joint axis: links between gut inflammation and spondyloarthritis
Gracey, E., Vereecke, L., McGovern, D., Fröhling, M., Schett, G., Danese, S., De Vos, M., Van den Bosch, F., & Elewaut, D. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0454-9 · Cited by 193
Li, T., Wang, C., Liu, Y., Li, B., Zhang, W., Wang, L., Yu, M., Zhao, X., Du, J., Zhang, J., et al. (2020) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjz132 · Cited by 199
Sundman, M. H., Chen, N.-K., Subbian, V., & Chou, Y.-H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.05.009 · Cited by 199
Parkinson's Disease: A Multisystem Disorder
Costa, H. N., Esteves, A. R., Empadinhas, N., & Cardoso, S. M. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00934-6 · Cited by 181
“This relationship is further corroborated by the fact that patients with inflammatory bowel disease (IBD) have a higher risk of developing PD [53].”
BackgroundInfluentialRegulation of intestinal permeability: The role of proteases
Van Spaendonk, H., Ceuleers, H., Witters, L., Patteet, E., Joossens, J., Augustyns, K., Lambeir, A.-M., De Meester, I., De Man, J. G., & De Winter, B. Y. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i12.2106 · Cited by 190
Leaky Gut and the Ingredients That Help Treat It: A Review
Aleman, R. S., Moncada, M., & Aryana, K. J. (2023) · Molecules · doi:10.3390/molecules28020619 · Cited by 182
Schoultz, I., & Keita, Å. V. (2019) · Cells · doi:10.3390/cells8020193 · Cited by 185
“This in turn may damage the mucosa leading to the increased production of reactive oxygen species [3] and subsequently to pathological conditions, such as IBD, and a disturbed intestinal barrier function has today become a hallmark of the disease [4].”
BackgroundBancil, A. S., Sandall, A. M., Rossi, M., Chassaing, B., Lindsay, J. O., & Whelan, K. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa254 · Cited by 171
Hill, D. R., Huang, S., Nagy, M. S., Yadagiri, V. K., Fields, C., Mukherjee, D., Bons, B., Dedhia, P. H., Chin, A. M., Tsai, Y.-H., et al. (2017) · eLife · doi:10.7554/elife.29132 · Cited by 175
“Increases in epithelial barrier permeability occur in the setting of inflammation (Ahmad et al., 2017; Michielan and D’Incà, 2015) and infectious disease (Shawki and McCole, 2017).”
Tight junctions: from molecules to gastrointestinal diseases
Moonwiriyakit, A., Pathomthongtaweechai, N., Steinhagen, P., Chantawichitwong, P., Satianrapapong, W., & Pongkorpsakol, P. (2022) · Tissue Barriers · doi:10.1080/21688370.2022.2077620 · Cited by 184
The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract
Bilski, J., Mazur-Bialy, A., Wojcik, D., Zahradnik-Bilska, J., Brzozowski, B., Magierowski, M., Mach, T., Magierowska, K., & Brzozowski, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/9074601 · Cited by 170
Ahmad, R., Rah, B., Bastola, D. K., Dhawan, P., & Singh, A. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-04989-8 · Cited by 173
A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity
Kumar, A., Priyamvada, S., Ge, Y., Jayawardena, D., Singhal, M., Anbazhagan, A. N., Chatterjee, I., Dayal, A., Patel, M., Zadeh, K., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.008 · Cited by 164
Phytochemicals and inflammatory bowel disease: a review
Hossen, I., Wu, H., Ting, L., Mehmood, A., Jingyi, S., Xu, D., Yanping, C., Hongqing, W., Zhipeng, G., Zhang, K., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1570913 · Cited by 167
Kaulmann, A., & Bohn, T. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9346470 · Cited by 163
“In both diseases, the epithelial lining of the gut is in part destroyed, resulting in perturbed permeability of the mucosal barrier, malabsorption of nutrients, and absorption of compounds by-passing the enterocytes, causing, for example, allergic reactions, a circumstance often described as “leaky gut syndrome” [2, 3…”
BackgroundGut microbiota, dietary intakes and intestinal permeability reflected by serum zonulin in women
Mörkl, S., Lackner, S., Meinitzer, A., Mangge, H., Lehofer, M., Halwachs, B., Gorkiewicz, G., Kashofer, K., Painold, A., Holl, A. K., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1784-0 · Cited by 166
Alhasson, F. A., Das, S., Seth, R. K., Dattaroy, D., Chandrashekaran, V., Ryan, C. N., Chan, L. S., Testerman, T. L., Burch, J. B., Hofseth, L. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172914 · Cited by 154
Panpetch, W., Hiengrach, P., Nilgate, S., Tumwasorn, S., Somboonna, N., Wilantho, A., Chatthanathon, P., Prueksapanich, P., & Leelahavanichkul, A. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1662712 · Cited by 151
Mo, J., Ni, J., Zhang, M., Xu, Y., Li, Y., Karim, N., & Chen, W. (2022) · Antioxidants · doi:10.3390/antiox11091674 · Cited by 167
Lajczak, N., Porru, E., Fallon, C. M., Smyth, J. S., Curley, C. E., McCarron, P. A., Tambuwala, M. M., Roda, A., & Keely, S. J. (2020) · Physiological Reports · doi:10.14814/phy2.14456 · Cited by 157
Elderman, M., Sovran, B., Hugenholtz, F., Graversen, K., Huijskes, M., Houtsma, E., Belzer, C., Boekschoten, M., de Vos, P., Dekker, J., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184274 · Cited by 145
Abdulqadir, R. F., Engers, J., & Al–Sadi, R. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.102026 · Cited by 154
Macrophages Maintain Epithelium Integrity by Limiting Fungal Product Absorption
Chikina, A. S., Nadalin, F., Maurin, M., Jouve, M. J., Thomas-Bonafos, T., Li, X. V., Lameiras, S., Baulande, S., Henri, S., MALISSEN, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.048 · Cited by 151
Kang, M., & Martín, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.04.003 · Cited by 151
Cytokines and intestinal epithelial permeability: A systematic review
Meyer, F., Wendling, D., Demougeot, C., Prati, C., & Verhoeven, F. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103331 · Cited by 145
Cheng, H., Liu, J., Tan, Y., Feng, W., & Peng, C. Y. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.10.003 · Cited by 149
The Regulation of Intestinal Mucosal Barrier by Myosin Light Chain Kinase/Rho Kinases
Jin, Y., & Blikslager, A. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103550 · Cited by 146
“Intestinal barrier dysfunction is believed to be a critical factor in the pathogenesis of IBD because increased paracellular permeability has been identified in both active and quiescent disease states of IBD, and increased permeability results in disease relapse in patients with CD [79].”
BackgroundEmerging pharmacotherapy for inflammatory bowel diseases
Luo, H., Cao, G., Luo, C., Tan, D., Vong, C. T., Xu, Y., Wang, S., Lu, H., Wang, Y., & Jing, W. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106146 · Cited by 138
Zhou, H., Sun, L., Zhang, S., Zhao, X. Y., Gang, X., & Wang, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00125 · Cited by 144
Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases
Massier, L., Blüher, M., Kovacs, P. L., & Chakaroun, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.616506 · Cited by 132
“In the following years research on intestinal permeability focused on autoimmune and inflammatory diseases such as celiac disease (19, 20) or Crohn’s disease (21).”
BackgroundInfluentialKulkarni, N., Jain, P., Shindikar, A., Suryawanshi, P., & Thorat, N. D. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119351 · Cited by 130
Serum zonulin in patients with inflammatory bowel disease: a pilot study
Caviglia, G. P., Dughera, F., Ribaldone, D. G., Rosso, C., Abate, M. L., Pellicano, R., Bresso, F., Smedile, A., Saracco, G. M., & Astegiano, M. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05787-7 · Cited by 140
“7 In the setting of IBD, it is supposed that impaired intestinal permeability represents an early event preceding disease onset.(8) The passage of non-self-antigens in the lamina propria may trigger the immune response mediated by cytokines such as interferon (IFN)-γ and tumor necrosis factor (TNF)-α which in turn may…”
BackgroundThe complex task of measuring intestinal permeability in basic and clinical science
Galipeau, H. J., & Verdu, E. F. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12871 · Cited by 130
Blomberg, J., Gottfries, C., Elfaitouri, A., Rizwan, M., & Rosén, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00229 · Cited by 136
Wu, H. M., Chen, Q.-Y., Wang, W., Chu, S., Liu, X., Liu, Y., Tan, C., Zhu, F., Deng, S., Dong, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110937 · Cited by 125
Impact of food-derived bioactive peptides on gut function and health
Bao, X., & Wu, J. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110485 · Cited by 129
Paediatric specific dosage forms: Patient and formulation considerations
Khan, D., Kirby, D. J., Bryson, S., Shah, M., & Mohammed, A. R. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121501 · Cited by 122
Emergence and significance of carbohydrate-specific antibodies
Kappler, K., & Hennet, T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0105-9 · Cited by 118
Schlegel, N., Boerner, K., & Waschke, J. (2020) · Acta Physiologica · doi:10.1111/apha.13492 · Cited by 129
Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
Gareb, B., Otten, A. T., Frijlink, H. W., Dijkstra, G. D. H., & Kosterink, J. G. W. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060539 · Cited by 122
“These results indicate that V565 could be absorbed during colitis, presumable by the enhanced permeability and retention effect of the inflamed colon [93].”
BackgroundImmunity, microbiota and kidney disease
Knauf, F., Brewer, J. R., & Flavell, R. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0118-7 · Cited by 123
Ramos, A. D. S., Viana, G. C. S., Brígido, M. M., & Almeida, J. F. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105779 · Cited by 124
Ahlawat, S., Kumar, P., Mohan, H., Goyal, S., & Sharma, K. K. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1876631 · Cited by 117
Liu, W., Luo, X., Tang, J., Mo, Q., Zhong, H., Zhang, H., & Feng, F. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02431-w · Cited by 121
Chen, W.-Y., Wang, M., Zhang, J., Barve, S. S., McClain, C. J., & Joshi‐Barve, S. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.015 · Cited by 112
Bigeh, A., Sanchez, A. M., Maestas, C. M., & Gulati, M. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.10.001 · Cited by 117
Alterations in Intestinal Permeability: The Role of the “Leaky Gut” in Health and Disease
Stewart, A. S., Pratt-Phillips, S. E., & Gonzalez, L. M. (2017) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2017.02.009 · Cited by 127
“Zinc is a trace element which functions in cellular turnover, regulation, and repair and is a key component of several enzyme systems [1,154].”
BackgroundGhosh, S. S., He, H., Wang, J., Gehr, T. W. B., & Ghosh, S. (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1425085 · Cited by 120
Intestinal permeability disturbances: causes, diseases and therapy
Macura, B., Kiecka, A., & Szczepanik, M. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01496-9 · Cited by 117
“Evaluation of the level of intestinal barrier permeability is possible during indirect or direct diagnostic tests [124].”
BackgroundMolecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases
Lee, J., Wasinger, V. C., Yau, Y. Y., Chuang, E., Yajnik, V., & Leong, R. W. L. (2018) · Proteomes · doi:10.3390/proteomes6020017 · Cited by 110
Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn’s Disease
Chervy, M., Barnich, N., & Denizot, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103734 · Cited by 113
“Deficient barrier function is frequently observed in CD patients and is predictive of relapses in CD [76].”
BackgroundSimanenkov, V. I., Maev, I. V., Ткачева, О. Н., Alekseenko, S. A., Андреев, Д. Н., Bordin, D. S., Vlasov, T. D., Vorobyeva, N. M., Grinevich, V. B., Владимировна, Г. И., et al. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2758 · Cited by 113
Kropp, C., Corf, K. L., Relizani, K., Tambosco, K., Martinez, C., Chain, F., Rawadi, G., Langella, P., Claus, S. P., & Martín, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90885-1 · Cited by 118
The Gut-Liver Axis in Cholestatic Liver Diseases
Blesl, A., & Stadlbauer, V. (2021) · Nutrients · doi:10.3390/nu13031018 · Cited by 112
Capucilli, P., Cianferoni, A., Grundmeier, R. W., & Spergel, J. M. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.08.022 · Cited by 105
Omega-3 Polyunsaturated Fatty Acids and the Intestinal Epithelium—A Review
Durkin, L., Childs, C. E., & Calder, P. C. (2021) · Foods · doi:10.3390/foods10010199 · Cited by 104
“Disruption of intestinal epithelium function leads to increased permeability and loss of immunological control, which is believed to contribute to a number of pathological states and diseases, including inflammatory bowel diseases (Crohn’s disease and ulcerative colitis), coeliac disease and irritable bowel syndrome […”
BackgroundKim, H., Venâncio, V. P., Fang, C., Dupont, A. W., Talcott, S. T., & Mertens‐Talcott, S. U. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.01.002 · Cited by 100
Intestinal mucus barrier: a missing piece of the puzzle in food allergy
Parrish, A., Boudaud, M., Kuehn, A., Ollert, M. W., & Desai, M. S. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.10.004 · Cited by 101
Milk miRNAs: simple nutrients or systemic functional regulators?
Melnik, B. C., Kakulas, F., Geddes, D. T., Hartmann, P. E., John, S. M., Carrera‐Bastos, P., Cordain, L., & Schmitz, G. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0101-2 · Cited by 96
“In this regard, intestinal permeability has to be considered which is increased during the postnatal period and in inflammatory bowel diseases [45, 46].”
BackgroundZhang, S.-X., Xu, W., Wang, H., Cao, M., Li, M., Zhao, J., Hu, Y., Wang, Y., Li, S., Xie, Y., et al. (2019) · Cell Proliferation · doi:10.1111/cpr.12673 · Cited by 96
Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease
Li, D., Yang, M., Xu, H., Zhu, M., Zhang, Y., Tian, C., Nie, Y., Wang, J., Liang, Y., Yao, J., et al. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01190e · Cited by 100
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
Herrick, M. K., & Tansey, M. G. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00170-1 · Cited by 102
Al-Sadi, R., Engers, J., Haque, M., King, S., Al-Omari, D., & Ma, T. Y. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249544 · Cited by 93
“Clinical studies in IBD patients have shown the key role of intestinal TJ barrier function in the pathogenesis of intestinal inflammation and emphasized on the enhancement of intestinal barrier which correlated with sustained long-term clinical remission [5, 6].”
BackgroundThe connection of circadian rhythm to inflammatory bowel disease
Gombert, M., Carrasco‐Luna, J., Arboledas, G. P., & Codoñer‐Franch, P. (2018) · Translational research · doi:10.1016/j.trsl.2018.12.001 · Cited by 95
Tanwar, H., Gnanasekaran, J. M., Allison, D. L., Chuang, L.-S. F., He, X., Aimetti, M., Baima, G., Costalonga, M., Cross, R. K., Sears, C. L., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae028 · Cited by 96
Chen, S.-W., Wang, P., Liu, Y., Sun, L., Zhu, J., Zuo, S., Ma, J., Li, T.-Y., Zhang, J., Chen, G., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000932 · Cited by 90
Nguyen, T. T., Trinh, N., Tran, H. N., Tran, H. T., Le, P. Q., Ngo, D., Tran‐Van, H., Toi, V. V., Vong, L. B., & Nagasaki, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.042 · Cited by 90
Lechuga, S., Neto, M. B. B., Naydenov, N. G., Rieder, F., & Ivanov, A. I. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1108289 · Cited by 95
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Xu, B., Li, Y., Xu, M. Q., Yu, C., Lian, M., Tang, Z., Li, C.-X., & Lin, Y. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.168 · Cited by 87
Knox, N., Forbes, J. D., Peterson, C.-L., Domselaar, G. V., & Bernstein, C. N. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000305 · Cited by 94
Intestinal Alkaline Phosphatase: A Review of This Enzyme Role in the Intestinal Barrier Function
Santos, G. M., Ismael, S., Morais, J., Araújo, J. R., Faria, A., Calhau, C., & Marques, C. (2022) · Microorganisms · doi:10.3390/microorganisms10040746 · Cited by 99
Borisova, M. A., Achasova, K. M., Morozova, K. N., Andreyeva, E. N., Litvinova, E. A., Ogienko, A. A., Morozova, M. V., Berkaeva, M. B., Владимировна, К. Е., & Kozhevnikova, E. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-78141-4 · Cited by 95
The leaky gut and the gut microbiome in sepsis – targets in research and treatment
Chancharoenthana, W., Kamolratanakul, S., Schultz, M. J., & Leelahavanichkul, A. (2023) · Clinical Science · doi:10.1042/cs20220777 · Cited by 96
Psychological co-morbidities in COPD: Targeting systemic inflammation, a benefit for both?
Pelgrim, C. E., Peterson, J. D., Gosker, H. R., Schols, A. M. W. J., van Helvoort, A., Garssen, J., Folkerts, G., & Kraneveld, A. D. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.001 · Cited by 89
“This “leaky gut” phenomenon is one of the characteristics of IBD as well (Michielan and D’Incà, 2015) and can promote the leakage of inflammatory mediators and aggravate systemic inflammation.”
BackgroundWang, D., Cai, M., Wang, T., Liu, T., Huang, J., Wang, Y., & Granato, D. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109409 · Cited by 85
Gut Barrier Dysfunction and Bacterial Lipopolysaccharides in Colorectal Cancer
Li, Q., von Ehrlich-Treuenstätt, V., Schardey, J., Wirth, U., Zimmermann, P., Andrassy, J., Bazhin, A. V., Werner, J., & Kühn, F. (2023) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-023-05654-4 · Cited by 91
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.